Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/301431 
Year of Publication: 
2024
Series/Report no.: 
I4R Discussion Paper Series No. 142
Publisher: 
Institute for Replication (I4R), s.l.
Abstract: 
Banerjee, Duflo, and Sharma (BDS, 2021a) conduct a ten-year follow-up of a randomized transfer program in West Bengal. BDS find large effects on consumption, food security, income, and health. We conduct a replicability assessment. First, we successfully reproduce the results, thanks to a perfectly documented reproduction package. Results are robust across alternative specifications. We furthermore assess the paper's pre-specification diligence and the reporting in terms of external and construct validity. While the paper refers to a pre-registration, it lacks a pre-analysis plan. Assessing the validity of findings for other contexts is difficult absent necessary details about the exact treatment delivery.
Subjects: 
replicability
randomized controlled trial
transfer programs
research transparency
JEL: 
A1
O12
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.